Skip to content
Review Open access

The Impact of Metabolic and Bariatric Surgery on Nutritional Status and Sarcopenia: A Narrative Overview of Underlying Mechanisms, Clinical Implications, and Prevention Strategies

Sep 2026 · Nutrients · Vol 18 · 0 citations · 111 references
Medicine

TL;DR

The recent literature highlights a high and increasing prevalence of muscle loss after surgery, driven by reduced protein intake, micronutrient deficiencies, hormonal changes, and decreased mechanical loading.

Abstract

Bariatric surgery is the most effective treatment for severe obesity, leading to significant and sustained weight loss and improvement in metabolic comorbidities. However, it is also associated with substantial changes in body composition and nutritional status, including the risk of sarcopenia and sarcopenic obesity. This review aims to summarize current evidence on the interplay between metabolic and bariatric surgery, nutritional alterations, and skeletal muscle health. The recent literature highlights a high and increasing prevalence of muscle loss after surgery, driven by reduced protein intake, micronutrient deficiencies, hormonal changes, and decreased mechanical loading. Despite these challenges, improvements in metabolic health and physical function are often observed, suggesting a complex relationship between muscle mass and functional outcomes. A multidisciplinary approach, including nutritional optimization and structured exercise interventions, is essential to mitigate muscle loss and function and improve long-term outcomes. Further research is needed to standardize diagnostic criteria and develop targeted strategies for prevention and management.

Read PDF

Similar papers

Review Open access Aug 2026

SARCOPENIC OBESITY IN THE ERA OF INCRETIN-BASED THERAPIES: DIAGNOSTIC CHALLENGES, THE RISK OF MUSCLE MASS LOSS, AND PREVENTION STRATEGIES

Introduction and purpose. Sarcopenic obesity (SO) is defined by the coexistence of excess adiposity and reduced muscle mass and function and is associated with disability, frailty, cardiometabolic disease, and increased mortality. This review aims to summarize current evidence on the definition and diagnosis of SO, ass...

A. Wolszczak, Weronika Martynowska, Michał Hajt et al. · 0 citations
Review Open access Sep 2026

Holistic Treatment of Obesity: The Importance of Integrating Pharmacotherapy, Dietary Therapy, and Physical Activity for Effective and Sustained Weight Loss

Introduction. Obesity is a chronic, complex, relapsing disease requiring long-term, individualized management. Incretin-based pharmacotherapy has increased the potential for clinically meaningful weight loss, but maintaining outcomes and limiting adverse body-composition changes also require dietary therapy and physica...

M. Iwaszko, Marcelina Skajewska, Julia Stojko et al. · 0 citations
Review Sep 2026

[Sarcopenia in gastrointestinal oncology: Diagnostic criteria, clinical implications and management].

Sarcopenia is defined as a loss of muscle mass and strength. It represents a frequent and multifactorial complication in patients with gastrointestinal cancers, resulting from the combined effects of malnutrition, chronic inflammation, metabolic alterations, and reduced physical activity level. Its assessment relies on...

Géraldine M. Camilleri, Eléa Janvier, F. Pigneur et al. · 0 citations
Review Open access Oct 2026

Exercise, Nutrition and GLP-1 Medicines to Improve Body Weight and Muscle Function in Heart Failure with Preserved Ejection Fraction

This narrative review synthesizes current evidence on lifestyle, pharmacological, surgical, and multimodal interventions targeting muscle strength, body composition, and functional capacity in HFpEF with sarcopenia and/or obesity. Exercise, particularly concurrent endurance and resistance training protocols, improve ae...

K. Prokopidis, Aniket S. Joshi, Søren Gam et al. · 0 citations
Review Open access Oct 2026

GLP-1-Based Pharmacotherapies and Skeletal Muscle Health in Obesity: A Narrative Review of Body Composition, Muscle Function, and Sarcopenia-Related Outcomes

Background: Obesity is associated with impaired skeletal muscle health and sarcopenic obesity. GLP-1-based pharmacotherapies induce weight loss, but accompanying reductions in fat-free or lean mass raise concerns about skeletal muscle loss. Conversely, reductions in adiposity, inflammation, insulin resistance, and intr...

Justyna Knapik, Weronika Fic, Ewelina Polak-Szczybyło · 0 citations
Review Open access Oct 2026

Sarcopenic obesity in older adults: the dual burden of muscle loss and fat gain. Clinical consequences, diagnostic challenges, and integrated management strategies

Sarcopenic obesity is an emerging geriatric syndrome defined by the simultaneous presence of reduced skeletal muscle mass and function alongside excess adiposity. As populations age and obesity prevalence rises, this condition has grown in clinical importance, carrying risks of frailty, falls, disability, metabolic syn...

Harishchandra Chaudhari, Gaurav Chaudhary, Y. Gaikwad et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.